Antioxidants: Positive or Negative Actors?
暂无分享,去创建一个
B. Salehi | M. Sharifi-Rad | J. Sharifi‐Rad | M. Martorell | N. Martins | A. Sureda | P. Maurya | J. Arbiser | Pradeep Kumar
[1] S. Antonyuk,et al. The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation , 2018, Nature Communications.
[2] Maja A. Marinović,et al. De novo expression of transfected sirtuin 3 enhances susceptibility of human MCF-7 breast cancer cells to hyperoxia treatment , 2018, Free radical research.
[3] M. Maes,et al. Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder , 2018, Molecular Neurobiology.
[4] Marcel Deponte. The Incomplete Glutathione Puzzle: Just Guessing at Numbers and Figures? , 2017, Antioxidants & redox signaling.
[5] Ash A. Alizadeh,et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. , 2017, Cancer discovery.
[6] R. Gulati,et al. Vitamin A toxicity presenting as bone pain , 2017, Archives of Disease in Childhood.
[7] A. Dinkova-Kostova,et al. The multifaceted role of Nrf2 in mitochondrial function , 2016, Current opinion in toxicology.
[8] J. Arbiser,et al. SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis , 2016, Oncotarget.
[9] Lei Wang,et al. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction , 2016, Oncotarget.
[10] S. Powers,et al. Exercise‐induced oxidative stress: past, present and future , 2016, The Journal of physiology.
[11] A. Sidoroff,et al. Influence of Vitamins on Secondary Reactive Oxygen Species Production in Sera of Patients with Resectable NSCLC , 2016, Diseases.
[12] Pawar Rk,et al. Antioxidants and their role in nurture human life and industry: A review , 2016 .
[13] Toshinori Ito,et al. Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment , 2016, Integrative cancer therapies.
[14] P. Maurya,et al. Quercetin-modulated erythrocyte membrane sodium-hydrogen exchanger during human aging: correlation with ATPase’s , 2016, Archives of physiology and biochemistry.
[15] P. Álvarez,et al. Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results , 2015, Oxidative medicine and cellular longevity.
[16] Chih-Yi Chen,et al. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2 , 2015, Oncotarget.
[17] J. Viña,et al. Redox modulation of mitochondriogenesis in exercise. Does antioxidant supplementation blunt the benefits of exercise training? , 2015, Free radical biology & medicine.
[18] Dean P. Jones,et al. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3 , 2015, Nature Communications.
[19] J. Arbiser,et al. The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer. , 2014, Future medicinal chemistry.
[20] Emily N. J. Ord,et al. Oxidative Stress and the Use of Antioxidants in Stroke , 2014, Antioxidants.
[21] Matthew E. Welsch,et al. Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.
[22] Liang-Jun Yan. Positive oxidative stress in aging and aging-related disease tolerance☆ , 2014, Redox biology.
[23] Danny L Wang,et al. SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. , 2013, Free radical biology & medicine.
[24] B. Halliwell. The antioxidant paradox: less paradoxical now? , 2013, British journal of clinical pharmacology.
[25] J. Chin,et al. Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Crowley,et al. Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial ( SELECT ) , 2011 .
[27] Siegfried Hekimi,et al. Taking a "good" look at free radicals in the aging process. , 2011, Trends in cell biology.
[28] Scott E. Kern,et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.
[29] A. Dinkova-Kostova,et al. The cytoprotective role of the Keap1–Nrf2 pathway , 2011, Archives of Toxicology.
[30] Christophe Tzourio,et al. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials , 2010, BMJ : British Medical Journal.
[31] W. Willett,et al. Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies , 2010, Cancer Causes & Control.
[32] N. Chen,et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. , 2010, Cancer research.
[33] M. Garcia-Conesa,et al. Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. , 2010, Molecular nutrition & food research.
[34] I. Papassotiriou,et al. FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus. , 2009, Metabolism: clinical and experimental.
[35] P. Galan,et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. , 2009, The American journal of clinical nutrition.
[36] S. Ishikawa,et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. , 2009, Cancer research.
[37] R. Newman,et al. Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials , 2008, International journal of cancer.
[38] A. Vickers,et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? , 2008, Journal of the National Cancer Institute.
[39] P. Nguyen,et al. DNMT1 as a Molecular Target in a Multimodality-Resistant Phenotype in Tumor Cells , 2008, Molecular Cancer Research.
[40] P. Canter. Herb, Nutrient, and Drug Interactions: Clinical Implications and Therapeutic Strategies , 2007 .
[41] N. Pattabiraman,et al. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. , 2007, Biochemistry.
[42] Dean P. Jones. Redefining oxidative stress. , 2006, Antioxidants & redox signaling.
[43] Mar Larrosa,et al. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. , 2006, Journal of agricultural and food chemistry.
[44] Timothy H Murphy,et al. Induction of the Nrf2-driven Antioxidant Response Confers Neuroprotection during Mitochondrial Stress in Vivo* , 2005, Journal of Biological Chemistry.
[45] G. Koren,et al. Pregnancy outcome following high doses of Vitamin E supplementation. , 2005, Reproductive toxicology.
[46] R. Clayman. Effect of Vitamin C Supplements on Urinary Oxalate and pH in Calcium Stone-Forming Patients , 2005 .
[47] J. Arbiser,et al. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[48] Alain Favier,et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. , 2004, Archives of internal medicine.
[49] A. Folsom,et al. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? , 2004, The American journal of clinical nutrition.
[50] P. Galan,et al. A Randomized, Placebo-Controlled Trial of the Health Effects of Antioxidant Vitamins and Minerals , 2004 .
[51] B. Cassileth,et al. Herb-Drug Interactions in Oncology , 2003 .
[52] I. Heilberg,et al. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. , 2003, Kidney international.
[53] A. Choi,et al. Identification of Activating Transcription Factor 4 (ATF4) as an Nrf2-interacting Protein , 2001, The Journal of Biological Chemistry.
[54] N. Binkley,et al. Hypervitaminosis A and bone. , 2009, Nutrition reviews.
[55] G. Pascal,et al. Vitamin A in pregnancy: requirements and safety limits. , 2000, The American journal of clinical nutrition.
[56] J. Fahey,et al. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[57] B. Cartmel,et al. Effects of long-term intake of retinol on selected clinical and laboratory indexes. , 1999, The American journal of clinical nutrition.
[58] H Gerster,et al. High-dose vitamin C: a risk for persons with high iron stores? , 1999, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[59] J. Palmgren,et al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. , 1996, Journal of the National Cancer Institute.
[60] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[61] K. Rothman,et al. Teratogenicity of high vitamin A intake. , 1995, The New England journal of medicine.
[62] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[63] N. Davidson,et al. Chemoprotection by inducers of electrophile detoxication enzymes. , 1993, Basic life sciences.
[64] B. Halliwell,et al. The antioxidants of human extracellular fluids. , 1990, Archives of biochemistry and biophysics.
[65] H. Biesalski. Comparative assessment of the toxicology of vitamin A and retinoids in man. , 1989, Toxicology.